Pulmonology and Critical Care

Pulmonary Fibrosis and Interstitial Lung Disease

Pulmonary fibrosis and interstitial lung diseases (ILDs) are complex disorders characterized by inflammation and scarring of lung tissue, often leading to progressive respiratory failure. This session delves into updated classification systems, diagnostic criteria, and the role of high-resolution CT imaging and lung biopsies. Advances in antifibrotic therapies, including nintedanib and pirfenidone, and ongoing clinical trials exploring combination treatments are discussed. Emphasis is placed on early detection, multidisciplinary care, and personalized treatment plans based on disease subtype. The impact of comorbidities, patient-reported outcomes, and quality of life measures are integrated into clinical decision-making. The session also explores lung transplantation as a therapeutic option in advanced cases.